Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
BULLISH SIGNAL DETECTED
██.█% Sign up free to reveal

Medpace Holdings, Inc. (MEDP) AI Forecast

Our AI detected a significant signal for Medpace Holdings, Inc.. Create a free account to see the exact price target.

Free account • 30-day free trial

$MEDP Bullish Signal Full forecast available

Medpace Holdings, Inc. (MEDP) Stock Forecast 2025


Medpace Holdings, Inc. (MEDP) AI Stock Price Forecast & Investment Analysis

Medpace Holdings, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Medpace Holdings, Inc. (MEDP) - Comprehensive Stock Analysis & Investment Research

Deep dive into Medpace Holdings, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 12, 2026, 1:09 a.m. (UTC)

Medpace Holdings, Inc. Investment Summary

When evaluating whether Medpace Holdings, Inc. (MEDP) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Medpace Holdings, Inc. (MEDP) operates within the Industrial Applications and Services sector, specifically in the Services-Commercial Physical & Biological Research industry. The company employs approximately 5,385 people. With a market capitalization of $13 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Medpace Holdings, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Medpace Holdings, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Medpace Holdings, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Medpace Holdings, Inc.

Sign Up Free
Corporate Identity

Medpace Holdings, Inc. (Stock Symbol: MEDP) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Services-Commercial Physical & Biological Research industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Medpace Holdings, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Medpace Holdings, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Medpace Holdings, Inc....

Unlock Full Company Profile

Get complete details about Medpace Holdings, Inc.

Sign Up Free
Revenue & Growth Analysis

Medpace Holdings, Inc. generates annual revenues of $3 billion , indicating a well-established business with proven market demand.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Medpace Holdings, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Medpace Holdings, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Medpace Holdings, Inc....

Unlock Financial Analysis

Get complete financial metrics for Medpace Holdings, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Medpace Holdings, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial

30-day free trial • Cancel anytime

Strategic Market Position

Medpace Holdings, Inc. strategically competes in the highly dynamic Services-Commercial Physical & Biological Research marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Medpace Holdings, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company shows positive operational efficiency through free cash flow generation of $221 million annually , with year-over-year cash flow growth of 28.1%. Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.

Margin & Pricing Power Analysis

The company maintains a 28.7% gross margin reflecting moderate pricing power typical of many manufacturing, retail, or service businesses. While not exceptionally high, these margins provide adequate room for operating expenses and profit generation. Competitive pressures or cost increases could impact profitability if margins compress.

Operating margin of 250.7% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This strong operating margin indicates excellent cost control and efficient organizational structure relative to the revenue base.

Asset Utilization Efficiency

Asset turnover ratio of 0.86x indicates solid asset utilization efficiency appropriate for many manufacturing or mixed business models. This level suggests the company generates meaningful revenue from its asset base while maintaining necessary capital investments for operations.

Financial Strength & Leverage

Current ratio of 0.61 reflects potential liquidity concerns with current liabilities exceeding current assets. While some businesses operate successfully with negative working capital, this warrants understanding of the specific circumstances.

Medpace Holdings, Inc. (MEDP) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Medpace Holdings, Inc. stock analysis.

Deep dive into Medpace Holdings, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Medpace Holdings, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Medpace Holdings, Inc.: With a P/E ratio of 29.59, the market highly values future growth prospects.

P/E Ratio 29.59x
P/B Ratio 29.08x
Market Cap $13.35B
EPS $14.66
Book Value/Share $16.18
Revenue/Share $89.18
FCF/Share $4.79
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Medpace Holdings, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Medpace Holdings, Inc.: An ROE of 27.3% demonstrates excellent shareholder value creation.

ROE 27.3%
ROA 14.3%
ROIC 23.2%
Gross Margin 28.7%
Operating Margin 250.7%
Net Margin 150.4%
EBT Margin 18.0%
Tax Rate 8.6%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Medpace Holdings, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Medpace Holdings, Inc.: A current ratio of 0.61 suggests potential liquidity concerns.

Current Ratio 0.61x
Quick Ratio 0.53x
D/E Ratio 0.23x
Financial Leverage 2.22x
Interest Coverage 80.6x
Working Capital $34M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Medpace Holdings, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Medpace Holdings, Inc.: Free cash flow of $221M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $252M
Free Cash Flow $221M
Capital Spending -$31M
OCF Growth YoY 28.1%
FCF Growth YoY 23.6%
FCF/Sales 18.2%
CapEx/Sales 2.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Medpace Holdings, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Medpace Holdings, Inc.: An asset turnover of 0.86x suggests room for improvement in asset utilization.

Asset Turnover 0.86x
Receivables Turnover 7.7x
Fixed Assets Turnover 5.6x
Days Sales Outstanding 48 days
Payables Period 10 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Medpace Holdings, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Medpace Holdings, Inc.: With annual revenue of $2530M, Medpace Holdings, Inc. operates at significant scale.

Income Statement
Total Revenue $2.53B
SG&A Expense $9M
Cost of Goods Sold $71M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 26%
Cash & Short-term Investments 6%
Total Liabilities 55%
Short-term Debt 2%
Accounts Receivable 17%
Dividend & Shareholder Information
Shares Outstanding 28M
Growth Metrics (YoY)
EPS Growth 3.3%

Latest Medpace Holdings, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Medpace Holdings, Inc. (MEDP) stock price and investment outlook.

📰 We are currently updating our news feed for Medpace Holdings, Inc.. Check back soon for the latest market analysis and company updates.

Medpace Holdings, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Medpace Holdings, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Absci Corp ABSI ██% $368M -4.7x 1.8x
Bioaffinity Technologies, Inc. BIAF ██% $5M -1.1x 0.6x
Weed, Inc. BUDZ ██% $3M x 397.8x
Cannabis Bioscience International Holdings, Inc. CBIH ██% $5M x 0.1x
Charles River Laboratories International, Inc. CRL ██% $8.78B 19.3x 2.8x
Foxo Technologies Inc. FOXO ██% $310K x x
Icon Plc ICLR ██% $8.14B 8.7x 0.9x
Incyte Corp INCY ██% $19.06B 14.8x 3.7x
Iqvia Holdings Inc. IQV ██% $28.99B 21.3x 4.5x
Ispecimen Inc. ISPC ██% $2M -2.2x 0.8x
Medpace Holdings, Inc. MEDP ██% $13.35B 29.6x 29.1x
Maxcyte, Inc. MXCT ██% $84M -10.6x 0.5x
Inotiv, Inc. NOTV ██% $15M -1.3x 0.1x
National Research Corp NRC ██% $368M 31.8x 26.3x
Omniab, Inc. OABI ██% $283M -6.5x 1.1x
Optimus Healthcare Services, Inc. OHCS ██% $50K x x
Onemednet Corp ONMD ██% $34M 99.7x -1.1x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Medpace Holdings, Inc. Stock Forecast

How accurate are Medpace Holdings, Inc. stock predictions?

Our AI model shows a -16% Spearman correlation coefficient for MEDP predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Medpace Holdings, Inc. stock price forecasts?

Our analysis considers Medpace Holdings, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Medpace Holdings, Inc. a good investment in 2025?

Based on our AI analysis, Medpace Holdings, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Medpace Holdings, Inc. forecasts updated?

Medpace Holdings, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...